Recombinant Clostridium botulinum Translation initiation factor IF-2 (infB), partial

Shipped with Ice Packs
In Stock

Description

Definition and Biological Role

Recombinant Clostridium botulinum translation initiation factor IF-2 (infB), partial, refers to a genetically engineered fragment of the bacterial protein IF-2 encoded by the infB gene. IF-2 is essential for initiating protein synthesis by promoting ribosomal subunit association, recruiting the initiator tRNA (fMet-tRNA), and facilitating its binding to the ribosomal P-site . The "partial" designation indicates that the recombinant form lacks full-length sequence integrity, likely retaining functional domains such as GTPase activity or ribosomal binding regions.

Gene Structure and Protein Domains

The infB gene in bacteria typically encodes two isoforms (IF2α and IF2β) via alternative translational initiation sites. Key structural features include:

DomainFunctionEvidence in Bacterial Homologs
G2-G3GTP binding/hydrolysis, ribosome interactionBacillus stearothermophilus IF2-G2 structure
C1-C2fMet-tRNA binding, ribosomal subunit associationStructural dynamics in Bacillus IF2
N-terminal regionsIsoform differentiation (IF2α vs. IF2β)Edman degradation studies in E. coli

In Clostridium botulinum, the infB gene structure and domain organization are inferred from homologs like Bacillus and E. coli.

Recombinant Production and Validation

Recombinant IF-2 fragments are generated using expression systems such as E. coli or C. botulinum vectors. Key steps include:

  1. Cloning: Amplification of the infB fragment (e.g., G2-G3 or C1-C2 domains) into plasmids (e.g., pMVP410) .

  2. Expression: Induction in bacterial hosts under controlled conditions.

  3. Purification: Affinity chromatography (e.g., Ni-NTA for His-tagged proteins) .

  4. Functional Assays:

    • GTPase activity via GTP hydrolysis assays .

    • Ribosomal binding using in vitro dipeptide synthesis .

Applications and Research Gaps

Potential Uses:

  • Studying ribosomal initiation mechanisms in pathogenic clostridia.

  • Developing inhibitors targeting IF-2’s GTPase domain for antimicrobial purposes.

Current Limitations:

  • No direct structural or functional data on C. botulinum IF-2 exists in the reviewed literature.

  • Most insights are extrapolated from Bacillus or E. coli homologs .

Comparative Analysis of IF-2 Across Species

FeatureClostridium botulinum (Inferred)Bacillus stearothermophilusEscherichia coli
IsoformsLikely IF2α/IF2βIF2α/IF2β confirmedIF2α/IF2β confirmed
GTPase DomainPreserved (G2-G3)Structurally resolved Functional assays
tRNA BindingC-terminal domains (C1-C2)Independent mobility observed Critical for initiator tRNA

Future Directions

  1. Structural Resolution: Cryo-EM or X-ray crystallography of C. botulinum IF-2.

  2. Functional Knockout Studies: Assess IF-2’s role in toxin production or sporulation.

  3. Therapeutic Exploration: Screen IF-2 inhibitors against botulism.

Product Specs

Form
Lyophilized powder. We will preferentially ship the format we have in stock. If you have special format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery times vary by purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with normal blue ice packs by default. For dry ice shipment, please contact us in advance; extra fees apply.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute the protein in sterile deionized water to 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Generally, the liquid form has a 6-month shelf life at -20°C/-80°C, while the lyophilized form has a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process. If you require a specific tag type, please inform us, and we will prioritize its development.
Synonyms
infB; CBO2418; CLC_2265Translation initiation factor IF-2
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Clostridium botulinum (strain Hall / ATCC 3502 / NCTC 13319 / Type A)
Target Names
infB
Uniprot No.

Target Background

Function
An essential component for initiating protein synthesis. It protects formylmethionyl-tRNA from spontaneous hydrolysis and facilitates its binding to the 30S ribosomal subunits. It is also involved in GTP hydrolysis during 70S ribosomal complex formation.
Database Links

KEGG: cbh:CLC_2265

Protein Families
TRAFAC class translation factor GTPase superfamily, Classic translation factor GTPase family, IF-2 subfamily
Subcellular Location
Cytoplasm.

Q&A

What is the structure and function of Clostridium botulinum Translation Initiation Factor IF-2?

Translation Initiation Factor 2 (IF-2) in C. botulinum, like in other bacteria, consists of five structural domains with distinct functions :

  • N-domain (N-terminal domain): Less conserved, rich in alanine and charged amino acids, weakly structured, and dispensable for basic translational functions.

  • GI domain (residues 228-412 in B. stearothermophilus): Highly conserved and contains all structural motifs characteristic of GTP/GDP-binding proteins.

  • GII domain (residues 413-520): A highly conserved β-barrel module structurally homologous to domain II of elongation factors.

  • C-1 domain: A sturdy domain rich in helical structures.

  • C-2 domain (last 110 amino acids): Responsible for recognition and binding of fMet-tRNA.

Functionally, IF-2 catalyzes the binding of initiator fMet-tRNA in the ribosomal P site, increasing both the rate and fidelity of translation initiation . This positioning is essential for correct start codon selection and assembly of the complete translation initiation complex.

How does IF-2 interact with the ribosome during translation initiation?

The interaction between IF-2 and the ribosome involves specific contacts with both ribosomal subunits :

  • The GII domain of IF-2 is in proximity to helices H3, H4, H17, and H18 of 16S rRNA in the small subunit.

  • The junction of the C-1 and C-2 domains is near H89 and the thiostrepton region of 23S rRNA in the large subunit.

  • The C-2 domain is positioned close to P-site-bound tRNA.

  • The conserved GI domain interacts with the large subunit's factor-binding center.

Research suggests that the orientation of IF-2 on the 30S subunit changes during the transition from the 30S to 70S initiation complex . This dynamic positioning is crucial for proper formation of the translation initiation complex and subsequent protein synthesis.

Why is recombinant C. botulinum IF-2 important for research?

Recombinant C. botulinum IF-2 provides researchers with several advantages:

  • It allows for controlled expression and purification of the protein for in vitro translation studies.

  • Enables structure-function relationship studies through site-directed mutagenesis.

  • Facilitates comparative studies between C. botulinum and other bacterial IF-2 proteins.

  • Helps understand potential differences in translation initiation machinery that might be unique to this pathogenic organism.

  • Could provide insights for developing targeted interventions against botulism.

Understanding the translation mechanisms of C. botulinum contributes to our knowledge of how this pathogen functions at the molecular level, potentially revealing new approaches to combat botulism .

What challenges exist in expressing recombinant C. botulinum IF-2, and how can they be addressed?

Expressing recombinant C. botulinum proteins presents several significant challenges:

  • Expression system selection: Research on recombinant botulinum neurotoxins has shown that proteins produced in heterologous systems (e.g., E. coli) may have different properties compared to those expressed in endogenous systems. For example, endogenously produced mutant botulinum neurotoxins had ~100-1000-fold greater toxicity than their heterologously produced counterparts .

  • Protein folding and solubility issues: Large multi-domain proteins like IF-2 often face folding challenges in heterologous systems.

  • Codon optimization requirements: C. botulinum has different codon usage patterns compared to common expression hosts.

  • Potential toxicity to host cells: Some C. botulinum proteins may interfere with host cell processes.

  • Post-translational modifications: Differences between expression hosts and C. botulinum may affect protein function.

ChallengePotential SolutionConsiderations
Expression systemEndogenous C. botulinum expression systemRequires specialized facilities; slower growth
Cell-free protein synthesisCostly but avoids toxicity issues
Protein foldingCo-expression with chaperonesMay increase soluble protein yield
Expression at lower temperatures (16-20°C)Slower growth but better folding
Codon optimizationCodon-optimized synthetic geneAdditional cost but improved expression
ToxicityTightly regulated inducible systemsMinimizes leaky expression
Post-translational modificationsEukaryotic expression systemsHigher cost, potentially lower yield

The choice between heterologous and endogenous expression systems should be carefully considered based on specific research questions .

How do mutations in different domains of IF-2 affect its function in translation initiation?

The effects of mutations in different IF-2 domains vary based on the domain's role:

Experimental approaches to study these effects include site-directed mutagenesis, chemical modification of specific amino acids (e.g., using tethered nucleases), truncation analysis, and complementation studies with domain swaps from other species.

How can CRISPR-Cas9 technology be applied to study IF-2 function in C. botulinum?

CRISPR-Cas9 technology offers powerful approaches for studying IF-2 function in C. botulinum, similar to methods described for studying other genes in this organism :

  • Gene modification strategies:

    • Introduction of specific mutations to study domain functions

    • Implementation of the "bookmark" approach, which introduces a unique 24-nt sequence that can serve as a subsequent sgRNA target

    • Using the "watermark" concept through silent mutations to track gene modifications

  • Complementation studies:

    • After generating mutations, the system allows for rapid generation of complemented strains

    • The original mutant allele can be replaced with a functional copy of the deleted gene using CRISPR-Cas9 and the requisite sgRNA

  • Protocol implementation:

    • Design sgRNAs targeting the infB gene regions of interest

    • Create repair templates containing homology arms, desired mutations, and bookmark sequences

    • Deliver CRISPR-Cas9 components and repair template into C. botulinum

    • Screen transformants for successful editing

    • For complementation, design new sgRNAs targeting the bookmark sequence

    • Deliver CRISPR-Cas9 components with a repair template containing the wild-type sequence

This approach provides precise genetic manipulation while maintaining genomic context, allowing for rigorous functional studies of IF-2 in its native environment .

What techniques are most effective for studying IF-2-ribosome interactions?

Several complementary techniques provide valuable insights into IF-2-ribosome interactions:

  • Chemical nuclease probing:

    • Tethering chemical nucleases (Cu(II):1,10-orthophenanthroline and Fe(II):EDTA) to cysteine residues introduced into IF-2

    • Analyzing cleavage patterns in rRNA to determine proximity relationships

  • Cryo-electron microscopy (cryo-EM):

    • Visualization of IF-2 in ribosomal complexes at near-atomic resolution

    • Capturing different states of the initiation complex

  • Fluorescence-based approaches:

    • Förster resonance energy transfer (FRET) between labeled IF-2 and ribosomal components

    • Single-molecule FRET to observe dynamic changes during initiation

  • Cross-linking methods:

    • Site-specific cross-linking using bifunctional reagents

    • UV cross-linking with photoreactive amino acid analogs

  • Biochemical assays:

    • Filter-binding assays to measure complex formation

    • GTPase activity assays to monitor functional interactions

TechniqueAdvantagesLimitationsResolution
Chemical nuclease probingPrecise interaction mapping; works in solutionRequires engineering cysteines; potential structural perturbation5-10 Å
Cryo-EMDirect visualization; no labels neededRequires stable complexes; averaging of states2.5-4 Å
FRETDynamic measurements; works in solutionRequires fluorescent labeling; indirect measurement10-100 Å
Cross-linkingCaptures transient interactionsCan create artifacts; challenging analysisResidue-specific
Biochemical assaysFunctional relevance; quantitativeIndirect; limited structural informationN/A

Integrating these complementary approaches provides the most comprehensive understanding of IF-2-ribosome interactions .

What are the optimal methods for purifying recombinant C. botulinum IF-2?

Purification of recombinant C. botulinum IF-2 requires careful consideration of protein properties:

Recommended purification protocol:

  • Expression system selection:

    • Endogenous C. botulinum expression system for native-like properties

    • E. coli with codon optimization for higher yields, recognizing potential functional differences

  • Affinity tag selection:

    • N-terminal His6-tag (preferred due to dispensability of N-domain for function)

    • C-terminal tagging should be avoided as it may interfere with C-2 domain function in fMet-tRNA binding

  • Cell lysis conditions:

    • Buffer: 50 mM Tris-HCl pH 7.5, 300 mM NaCl, 5% glycerol, 1 mM DTT

    • Protease inhibitor cocktail to prevent degradation

    • Gentle lysis methods (e.g., lysozyme treatment followed by sonication)

  • Purification steps:

    • Immobilized metal affinity chromatography (IMAC) with Ni-NTA resin

    • Ion exchange chromatography using Resource Q column

    • Size exclusion chromatography for final polishing

  • Quality control assessments:

    • SDS-PAGE to verify purity

    • Mass spectrometry for accurate mass determination

    • Circular dichroism to verify secondary structure

    • Functional assays (GTP binding, fMet-tRNA binding)

When using different expression systems, it's critical to compare protein properties as significant functional differences have been observed between endogenously and heterologously expressed C. botulinum proteins .

How should researchers interpret contradictory results between heterologous and endogenous expression systems?

When faced with contradictory results between heterologously and endogenously expressed recombinant C. botulinum proteins, researchers should follow this analytical framework:

  • Systematic property comparison:

    • Structural integrity assessment through circular dichroism or limited proteolysis

    • Specific activity comparison in functional assays

    • Post-translational modification analysis by mass spectrometry

  • System-specific considerations:

    • Expression system effects on folding pathways

    • Different chaperone proteins influencing final structure

    • Codon usage differences affecting co-translational folding

  • Biological relevance evaluation:

    • The endogenous expression system likely produces more native-like protein

    • Heterologous systems may be suitable for specific applications despite differences

Based on research with recombinant botulinum neurotoxins, endogenously produced mutants showed ~100-1000-fold greater toxicity than their heterologously produced counterparts . This significant difference highlights the importance of expression system choice and suggests that endogenous expression may better preserve native protein properties for functional studies.

What statistical approaches are appropriate for analyzing IF-2 functional data?

Statistical analysis of IF-2 functional data requires approaches specific to the assays employed:

  • For binding assays (IF-2-ribosome, IF-2-fMet-tRNA):

    • Nonlinear regression to determine dissociation constants (Kd)

    • Scatchard analysis for multiple binding sites

    • One-way ANOVA with post-hoc tests for comparing multiple variants

  • For GTPase activity measurements:

    • Michaelis-Menten kinetics analysis to determine Km and kcat

    • Lineweaver-Burk plots to identify inhibition mechanisms

    • Two-way ANOVA for comparing effects of mutations and conditions

  • For in vitro translation assays:

    • Paired t-tests for comparing wild-type and mutant activities

    • Multiple regression for analyzing effects of various factors

    • Power analysis to determine appropriate sample sizes

  • For ribosome interaction studies:

    • Cluster analysis of chemical probing data

    • Bootstrap analysis for structure prediction reliability

    • Bayesian methods for integrating multiple data types

Recommended reporting practices:

  • Include a minimum of three independent biological replicates

  • Report both raw data and processed results when possible

  • Present exact p-values rather than threshold cutoffs

  • Use appropriate multiple testing corrections

  • Include measures of dispersion (standard deviation or standard error)

These statistical approaches ensure robust interpretation of experimental data when studying the complex functions of IF-2.

How can structural data on IF-2 be integrated with functional studies to develop a comprehensive model?

Integrating structural and functional data requires a systematic approach:

  • Mapping functional data onto structural models:

    • Identify residues critical for specific functions through mutagenesis

    • Correlate chemical modification sites with functional effects

    • Visualize conserved regions in the context of the 3D structure

  • Developing structure-based hypotheses:

    • Predict effects of mutations based on structural context

    • Design targeted mutations to test specific structural features

    • Use computational docking to model protein-protein interactions

  • Model refinement process:

    • Start with homology models based on related bacterial IF-2 structures

    • Refine models with experimental constraints from chemical probing

    • Validate models with new experimental data

  • Integration methodologies:

    • Combine low-resolution techniques (SAXS, cryo-EM) with high-resolution data

    • Use distance constraints from FRET and cross-linking

    • Apply molecular dynamics simulations to model conformational changes

This integrated approach can yield a dynamic model of IF-2 function that explains both structural arrangements and functional data, particularly for understanding the transition between 30S and 70S initiation complexes .

What contradictions exist in current research regarding IF-2 positioning on the ribosome?

Several contradictions exist in the research regarding IF-2 positioning:

  • 30S vs. 70S complex differences: Research suggests the orientation of IF-2 on the 30S subunit changes during the transition to the 70S initiation complex , but the exact nature of these changes remains debated.

  • Cross-linking vs. cryo-EM data discrepancies: Different techniques have yielded somewhat different models for IF-2 positioning on the ribosome.

  • Species-specific variations: Differences observed between IF-2 positioning in different bacterial species raise questions about the universality of proposed models.

  • Dynamic vs. static models: Some research supports a more dynamic model of IF-2 function with multiple conformations during initiation, while other data suggests more stable positioning.

Resolving these contradictions requires integrating multiple experimental approaches:

  • Cryo-EM studies at different stages of initiation

  • Time-resolved FRET experiments to capture dynamic changes

  • Cross-validation between chemical cross-linking and structural biology methods

  • Comparative studies between C. botulinum IF-2 and homologs from other species

Understanding these contradictions is essential for developing accurate models of IF-2 function during translation initiation .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.